VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ASRT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ASRTAssertio Holdings, Inc.
$23.50$152M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksASRTFinancials

Assertio Holdings, Inc. (ASRT) Financials

30Y historyFree accessUpdated daily

The company's top-line performance has deteriorated sharply, with revenue falling 62.5% in 2026Q1 while gross margins compressed to a concerning 13.9%.

ASRT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue102.16M118.71M124.96M152.07M156.23M111.01M108.08M229.53M311.77M380.72M455.9M342.74M390.36M134.21M90.82M132.97M80.76M57.73M34.84M65.58M9.55M4.41M202.57K981.99K1.66M3.67M1.78M115.33K800K600K300K
Revenue Growth %-14.16%-5%-17.83%-2.67%40.73%2.72%-52.91%-26.38%-18.11%-16.49%33.02%-12.2%190.87%47.78%-31.7%64.64%39.9%65.69%-46.87%586.63%116.81%2074.73%-79.37%-40.89%-54.78%106.81%1440.16%-85.58%33.33%100%-
Cost of Goods Sold56.88M65.39M39.23M27.02M18.75M15.83M15.77M9.51M18.48M72.6M87.41M67.9M15.15M7.09M6.04M5.54M8.1M5.26M5.77M2.6M1.6M908.52K0000-561.76K-643.49K-500K-200K0
COGS % of Revenue-55.08%31.39%17.77%12%14.26%14.59%4.14%5.93%19.07%19.17%19.81%3.88%5.28%6.65%4.17%10.03%9.11%16.57%3.96%16.76%20.62%-----31.63%-557.97%-62.5%-33.33%-
Gross Profit45.27M53.33M85.73M125.05M137.49M95.18M92.3M220.02M293.29M308.13M368.48M274.84M375.22M127.11M84.78M127.43M72.67M52.47M29.07M62.98M7.95M3.5M202.57K981.99K1.66M3.67M2.34M758.82K1.3M800K300K
Gross Margin %44.32%44.92%68.61%82.23%88%85.74%85.41%95.86%94.07%80.93%80.83%80.19%96.12%94.72%93.35%95.83%89.97%90.89%83.43%96.04%83.24%79.38%100%100%100%100%131.63%657.97%162.5%133.33%100%
Gross Profit Growth %--37.8%-31.44%-9.05%44.45%3.12%-58.05%-24.98%-4.81%-16.38%34.07%-26.75%195.18%49.94%-33.47%75.36%38.49%80.5%-53.85%692.22%127.36%1626.23%-79.37%-40.89%-54.78%57.12%208.11%-41.63%62.5%166.67%-
Operating Expenses68.02M70.55M110.21M368.58M98.08M85.76M174.46M414.45M229.03M337.06M343.97M355.14M138.4M117.8M115.13M96.73M69.04M74.54M46.16M15.45M49.56M30.01M26.54M30.38M30.09M17.99M10.08M6.25M4.6M2.1M800K
OpEx % of Revenue-59.43%88.2%242.38%62.78%77.25%161.42%180.57%73.46%88.53%75.45%103.62%35.45%87.77%126.77%72.74%85.49%129.13%132.5%23.55%518.87%681.18%13100.4%3093.76%1811.27%489.88%567.28%5418.75%575%350%266.67%
Selling, General & Admin66.32M68.86M76.95M69.74M48.1M56.55M104.22M110.44M119.22M195.69M204.5M199.35M121.13M104.98M97.65M81.54M48.93M40.24M26.4M26.69M22.67M11.64M5.18M3.48M5.37M2.53M2.03M1.87M2M1M400K
SG&A % of Revenue-58%61.58%45.86%30.79%50.94%96.43%48.12%38.24%51.4%44.86%58.17%31.03%78.22%107.52%61.32%60.59%69.71%75.76%40.7%237.32%264.21%2556.43%354.41%323.53%68.97%114.07%1622.86%250%166.67%133.33%
Research & Development1.71M1.69M3.82M2.84M004.21M10.11M8.04M38.62M32.63M72.44M7.12M8.07M15.46M15.19M20.11M34.3M27.27M23.34M26.89M18.37M21.36M26.9M24.71M15.46M7.49M3.73M2.1M900K400K
R&D % of Revenue-1.42%3.06%1.87%--3.9%4.4%2.58%10.14%7.16%21.14%1.82%6.02%17.03%11.42%24.9%59.41%78.26%35.58%281.55%416.98%10543.96%2739.36%1487.74%420.9%421.58%3237.92%262.5%150%133.33%
Other Operating Expenses0029.44M296M49.98M29.2M66.03M293.9M101.77M102.75M106.84M599K10.16M-249K481K000-7.5M-34.58M000000561.76K643.49K500K200K0
Operating Income-22.75M-17.22M-24.48M-243.54M39.41M9.42M-82.16M-194.43M43.66M-42.18M24.51M-50.4M236.81M9.32M-30.35M70.7M3.63M-22.07M-17.09M47.54M-41.61M-26.51M-26.33M-29.4M-28.43M-14.32M-7.74M-5.49M-3.3M-1.3M-500K
Operating Margin %-22.27%-14.51%-19.59%-160.15%25.22%8.49%-76.02%-84.71%14%-11.08%5.38%-14.71%60.67%6.94%-33.42%53.17%4.49%-38.23%-49.06%72.49%-435.62%-601.81%-13000.4%-2993.76%-1711.27%-389.88%-435.66%-4760.78%-412.5%-216.67%-166.67%
Operating Income Growth %-29.63%89.95%-718.03%318.13%111.47%57.75%-545.33%203.51%-272.1%148.63%-121.28%2441.74%130.7%-142.93%1850.29%116.42%-29.11%-135.96%214.25%-56.94%-0.67%10.42%-3.42%-98.5%-85.07%-40.94%-66.38%-153.85%-160%-
EBITDA3.83M12.78M1.35M-215.31M72.8M38.54M-55.72M-91.48M150.09M63.32M133.88M32.94M246.97M13.87M-28.33M71.12M4.06M-21.26M-15.95M48.4M-40.23M-25.37M-24.63M-28.35M-27.68M-13.71M-7.18M-4.85M-2.8M-1.1M-500K
EBITDA Margin %3.74%10.77%1.08%-141.59%46.6%34.71%-51.56%-39.86%48.14%16.63%29.37%9.61%63.27%10.33%-31.2%53.48%5.03%-36.83%-45.77%73.81%-421.17%-575.95%-12160.55%-2887.38%-1666.42%-373.25%-404.03%-4202.81%-350%-183.33%-166.67%
EBITDA Growth %203.91%844.72%100.63%-395.75%88.91%169.16%39.09%-160.95%137.02%-52.7%306.4%-86.66%1681.28%148.94%-139.84%1649.95%119.11%-33.34%-132.95%220.32%-58.54%-3%13.12%-2.43%-101.9%-91.05%-48.06%-73.11%-154.55%-120%-
D&A (Non-Cash Add-back)26.58M30M25.83M28.23M33.4M29.11M26.43M102.95M106.43M105.5M109.38M83.34M10.16M4.55M2.02M420K439K808K1.15M865K1.38M1.14M1.7M1.04M745.14K610.81K561.76K643.49K500K200K0
EBIT-22.75M-17.22M-20.68M24.94M56.77M9.67M-42.71M-5.11M106.86M-30.37M19.22M-49.8M237.03M10.52M-29.83M71.25M4.46M-21.02M-14.75M47.54M-41.61M-26.51M-26.33M-29.4M-28.43M-14.32M-7.74M-5.49M-3.34M-1.2M-500K
Net Interest Income-671K-410K182K-3.38M-7.96M-10.22M-15.93M-58.39M-67.56M-73.55M-83.23M-72.84M-23.71M-4.74M481K424K267K49K1.79M2.27M2.03M985.32K-439.87K-611.28K-631.46K-105.2K222.95K0000
Interest Income2.41M2.67M3.22M000001.2M0485K599K215K662K520K557K839K1.05M2.35M2.27M2.03M1.45M489.01K299.14K101.11K0222.95K0000
Interest Expense3.08M3.08M3.04M3.38M7.96M10.22M15.93M58.39M68.76M73.55M83.72M73.44M23.92M5.4M39K133K572K1M555K00459.74K928.88K910.42K732.57K105.2K00000
Other Income/Expense-12.7M-12.72M2.95M-10.52M-8.24M-9.98M71.38M-17.49M-5.68M-61.74M-89.01M-72.84M-23.71M-4.74M481K424K267K49K1.79M39.56M2.03M2.04M-439.87K-5.36K15.56M-3.17M-2.19M-12.02M536.86K0500K
Pretax Income-35.46M-29.94M-21.53M-254.05M31.17M-553K-10.78M-211.92M37.98M-103.92M-64.5M-123.24M213.11M4.58M-29.87M71.12M3.89M-22.02M-15.3M49.81M-39.58M-24.47M-26.77M-29.4M-12.86M-17.49M-9.93M-17.51M-2.8M00
Pretax Margin %-34.71%-25.22%-17.23%-167.06%19.95%-0.5%-9.97%-92.33%12.18%-27.3%-14.15%-35.96%54.59%3.41%-32.89%53.49%4.82%-38.15%-43.92%75.95%-414.36%-555.4%-13217.54%-2994.31%-774.33%-476.27%-558.82%-15178.98%-350%--
Income Tax235K435K52K77.89M-78.46M728K17.37M5.28M1.07M-1.43M24.22M-47.5M81.35M-38.73M-91K396K-4K-15K1K592K82.5K099K611.28K-17.37M105.2K1.96M11.72M-500K-100K500K
Effective Tax Rate %-0.66%-1.45%-0.24%-30.66%-251.75%-131.65%-161.2%-2.49%2.81%1.38%-37.55%38.54%38.17%-845.7%0.3%0.56%-0.1%0.07%-0.01%1.19%-0.21%0%-0.37%-2.08%135.03%-0.6%-19.79%-66.94%17.86%--
Net Income-35.69M-30.38M-21.58M-331.94M109.63M-1.28M-28.14M-217.2M36.91M-102.5M-88.72M-75.74M131.76M43.31M-29.78M70.73M3.9M-22.01M-15.3M49.22M-39.66M-24.47M-26.87M-30.02M-13.49M-17.6M-9.7M-17.21M-2.8M-1.2M-500K
Net Margin %-34.94%-25.59%-17.27%-218.28%70.17%-1.15%-26.04%-94.63%11.84%-26.92%-19.46%-22.1%33.75%32.27%-32.79%53.19%4.82%-38.12%-43.92%75.05%-415.23%-555.4%-13266.41%-3056.56%-812.35%-479.13%-546.27%-14921.74%-350%-200%-166.67%
Net Income Growth %-16.59%-40.75%93.5%-402.8%8657.77%95.45%87.04%-688.49%136.01%-15.53%-17.14%-157.48%204.21%245.44%-142.11%1715.35%117.7%-43.82%-131.09%224.1%-62.09%8.95%10.47%-122.42%23.33%-81.39%43.62%-514.6%-133.33%-140%-
Net Income (Continuing)-35.69M-30.38M-21.58M-331.94M109.63M-1.28M-28.14M-217.2M36.91M-102.5M-88.72M-75.74M131.76M43.31M-29.78M70.73M3.9M-22.01M-15.3M49.22M-39.66M-24.47M-26.87M-30.02M-13.49M-17.6M-9.7M-17.21M-2.8M-1.2M-500K
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)-5.55-4.74-3.45-70.0530.45-0.45-16.05-184.3534.50-98.10-86.85-75.60123.0045.00-31.9575.604.20-25.65-18.7563.00-57.30-36.90-46.50-73.65-55.35-103.35-79.35-159.45-26.55-16.20-7.20
EPS Growth %-19.06%-37.39%95.07%-330.05%6935.02%97.22%91.29%-634.35%135.17%-12.95%-14.88%-161.46%173.33%240.85%-142.26%1700%116.37%-36.8%-129.76%209.95%-55.28%20.65%36.86%-33.06%46.44%-30.25%50.24%-500.56%-63.89%-125%-
EPS (Basic)--4.74-3.45-70.0534.95-0.45-16.05-184.3534.65-98.10-87.00-75.60135.6045.60-31.9578.004.20-25.65-18.7563.60-57.30-36.90-46.50-73.65-55.35-103.35-79.35-159.45-26.55-16.20-7.20
Diluted Shares Outstanding6.43M6.4M6.35M4.74M3.64M2.88M1.75M1.18M1.07M1.05M1.02M1M1.11M959.07K931.54K934.83K889.35K858.66K812.98K772.55K691.96K663.69K577.15K407.64K244.05K170.34K122.17K107.91K105.3K74.07K69.44K
Basic Shares Outstanding6.43M6.4M6.35M4.74M3.13M2.88M1.75M1.18M1.06M1.05M1.02M1M971.55K945.6K931.54K909.38K875.55K858.66K812.98K765.85K691.96K663.69K577.15K407.64K244.05K170.34K122.17K107.91K105.3K74.07K69.44K
Dividend Payout Ratio-------------------------------

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and revenue erosion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Top Line Contraction Accelerates Sharply

According to the most recent quarterly financial data, Assertio Holdings experienced a severe revenue decline of 62.5% in 2026Q1, marking a significant deterioration from the 57.9% contraction observed in the prior quarter and highlighting the rapid erosion of the company's core specialty pharmaceutical product portfolio.

The consistent double-digit revenue declines suggest that the company's legacy assets are failing to maintain market relevance in a competitive payer environment. This trend indicates that the current commercial strategy is insufficient to offset the natural decay of the product lifecycle, raising concerns about the durability of the remaining revenue base.

Gross Margin Compression Signals Weakness

As reported in financial statements, Assertio's gross margin plummeted to 13.9% in 2026Q1, a stark departure from the 60% levels seen in previous periods, which suggests that the company is struggling with high manufacturing costs or unfavorable pricing dynamics relative to its specialty pharmaceutical peers.

The dramatic collapse in gross profitability implies that the cost of goods sold is no longer scaling efficiently with the shrinking revenue base. Investors should monitor whether this margin compression is a structural shift caused by royalty obligations or a temporary impact from inventory write-downs and product returns.

Operating Leverage Remains Deeply Negative

Based on the company's reported figures, operating margins reached a trough of -185.9% in 2026Q1, demonstrating that the firm's fixed SG&A expenses are significantly misaligned with its current revenue scale, effectively preventing any path to operational profitability under the existing cost structure and commercial footprint.

The inability to scale operating income despite fluctuations in revenue suggests that the company's overhead is too rigid for its current size. This lack of operating leverage indicates that management may need to pursue aggressive cost-cutting measures to prevent further depletion of the company's limited cash reserves.

Sustainability of Current Business Model

Data from the latest income statement indicates that the company's net loss of $18.9 million in 2026Q1, combined with a dwindling cash position, suggests that the current business model may be unsustainable without significant external capital or a radical pivot in the company's core operational strategy.

Short-sellers would likely focus on the widening gap between operating expenses and gross profit as evidence of a terminal decline in the asset base. The persistent negative earnings quality warrants further investigation into whether the company can maintain its commercial infrastructure without resorting to dilutive financing in the near term.

ASRT — Frequently Asked Questions

Quick answers to the most common questions about buying ASRT stock.

What was Assertio Holdings, Inc.'s (ASRT) revenue in 2025?

For fiscal year 2025, Assertio Holdings, Inc. (ASRT) reported total revenue of $118.7M. This represents a 39471.0% increase compared to $0.3M in 1996.

Is Assertio Holdings, Inc. (ASRT) profitable?

Assertio Holdings, Inc. (ASRT) reported a net loss of $30.4M for the fiscal year ending 2025.

What is Assertio Holdings, Inc.'s operating profit margin?

Assertio Holdings, Inc. (ASRT) reported an operating income of $-17.2M, resulting in an operating profit margin of -14.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Assertio Holdings, Inc.'s gross profit and gross margin?

Assertio Holdings, Inc. (ASRT) generated $53.3M in gross profit for the year, representing a gross profit margin of 44.9%. This demonstrates the company's core pricing power and production efficiency.